Richard L. Carpenter

This paper introduces EmitGCL, a deep-learning framework that predicts future metastasis in cancer with high accuracy, identifies biomarkers, and validates therapeutic targets.

This paper shows SUV39H1 is critical for maintaining glioblastoma stem cell properties and progression, and targeting it enhances chemotherapy effectiveness.

This study identifies HSF1 and MYC co-amplification in ovarian cancer and shows that targeting PLK1 is more effective in these cells, suggesting a potential precision medicine approach.

This paper shows that combining MYC and p53-R270H mutations in a mouse model generates high-grade serous ovarian and uterine serous carcinomas with human-like genetic and transcriptomic features.

This study shows HSF1 suppresses CD8+ T cell infiltration in breast tumors by reducing CCL5 expression, thereby preventing immune-mediated tumor destruction.